Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,229 public trials 1,177 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, Not Recruiting

Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy

NCT02432963

Conditions: Adenocarcinoma, Adult Solid Neoplasm, Bladder Carcinoma, +74 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases

NCT03824327

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

Immune Profiling of Stage III Non-small Cell Lung Cancer Patients Treated With Concurrent Chemoradiation and Adjuvant Durvalumab: A Prospective Observational Phase II Trial

NCT04432142

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Maastricht Radiation Oncology (MAASTRO clinic) Maastricht, Netherlands

View Trial Details

Active, Not Recruiting

Lazertinib+Pemetrexed/Carboplatin in Patients With EGFR Sensitizing Mutation Positive Recurrent or Metastatic Non-Small Cell Lung Cancer Failed to Prior Lazertinib

NCT05786430

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Yonsei University Health System, Severance Hospital Seoul, South Korea

View Trial Details

Active, Not Recruiting

A Study to Evaluate First-line Ipilimumab + Nivolumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT06487156

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Local Institution - 0001 Naples, Italy

View Trial Details

Active, Not Recruiting

Window of Opportunity Trial of Durvalumab (MEDI4736) to Identify Immune Dynamics in Operable Non-small Cell Lung Cancer (NSCLC) (MIRACLE)

NCT05206812

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Yonsei University Health System, Severance Hospital Seoul, South Korea

View Trial Details

Active, Not Recruiting

A Study of SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (SKB264-II-04) (MK-2870-003)

NCT05816252

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Chongqing University Cancer Hospital (Chongqing Cancer Hospital) Chongqing, Chongqing Municipality, China

Fujian Cancer Hospital Fuzhou, Fujian, China

Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China

View all 50 locations

View Trial Details

Active, Not Recruiting

Optimizing Endobronchial Ultrasound Sampling for Molecular Markers for NSCLC

NCT05560776

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations: Institut Universitaire de Cardiologie et Pneumologie de Quebec Québec, Quebec, Canada

View Trial Details

Active, Not Recruiting

A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer

NCT02779751

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations: Highlands Oncology Group - Duplicate 2 Springdale, Arkansas, United States

Univ of California San Francisco San Francisco, California, United States

University of Colorado School of Medicine Aurora, Colorado, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View all 24 locations

View Trial Details

Active, Not Recruiting

Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI

NCT05601973

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Chu Angers Angers, France

Centre Hospitalier d'Avignon Avignon, France

Centre Léon Bérard Lyon, France

AO SM Misericorida Perugia Perugia, Italy

View all 18 locations

View Trial Details

Carcinoma, Bronchogenic

Carcinoma, Bronchogenic trial results

Related conditions